Mural Oncology

Mural Oncology is a clinical-stage oncology company dedicated to developing innovative immunotherapies that can improve the lives of cancer patients. They specialize in cytokine-based immunotherapies, utilizing their expertise in protein engineering to create novel therapies that address unmet needs in a wide range of cancers. Their lead product candidate, nemvaleukin alfa, is an engineered interleukin-2 (IL-2) variant designed to enhance anti-tumor activity while mitigating toxicities associated with traditional IL-2 therapies.

Mural Oncology is actively engaged in clinical trials for nemvaleukin alfa in difficult-to-treat cancers such as platinum-resistant ovarian cancer and melanoma. They are also developing a pipeline of other cytokine-based immunotherapies, including IL-12 and IL-18 variants, aimed at further expanding the reach of immunotherapy and improving treatment outcomes for patients. The company's mission is to unlock the value of immunotherapy for more patients, with a focus on science-based decision making, inclusive collaboration, and rapid execution.

Mural Oncology offers flexible work arrangements to help employees balance work and life demands. Their benefits package includes a flexible paid time off program allowing employees time to focus on personal life.

Mural Oncology offers a competitive benefits package to its employees, encompassing healthcare, financial, and wellness programs. These benefits include comprehensive medical, dental, and vision insurance for employees and their families. Financial benefits include competitive salaries and bonuses, retirement savings plans, and the opportunity for equity participation. To support employee well-being, Mural provides wellness programs focused on physical fitness, nutrition, and mental health. The company also emphasizes flexibility, offering programs to help employees manage the demands of work and life. Additionally, employees can participate in a recognition program that allows them to acknowledge each other's achievements and contributions. Finally, a flexible paid time off program provides employees with time to focus on their personal lives outside of work.

Mural Oncology is a clinical-stage oncology company dedicated to developing innovative cytokine-based immunotherapies for the treatment of cancer. Their mission is to unlock the value of immunotherapy for more patients by leveraging their protein engineering platform to create novel therapies that can meaningfully improve the lives of those living with cancer. They are committed to expanding the reach of immunotherapy to include those who are currently ineligible or unresponsive to current treatments, with a focus on difficult-to-treat tumor types.

Mural Oncology promotes a culture that prioritizes science, collaboration, and agility. They value science-based decision making, encouraging open and diverse perspectives. They foster a culture of trust and transparency, emphasizing the importance of a shared mission. While serious about their work, Mural Oncology also understands the importance of fun and celebration, creating a balanced and engaging environment for their employees.

Mural Oncology is committed to fostering a workplace where all voices are heard and diverse perspectives are valued. They believe that an inclusive environment allows for a more dynamic exchange of ideas and information, leading to better decision-making and a stronger sense of shared ownership. This commitment is reflected in their core values, which emphasize inclusive collaboration, respectful communication, and a welcoming atmosphere where individuals are encouraged to bring their unique experiences and perspectives to the table.